Delivery Order SPE2DB22D3501-SPE2DB24FUS30
- Not listed
- The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $4,728.70 contract is for the delivery of RUXIENCE 500 MG/50 ML vial medication with an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,028.91 firm fixed price delivery order is for the RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a Delivery Order with a ceiling value of $7,072.52 for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract, which has a firm fixed price pricing type, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a child...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a firm fixed price delivery order, is for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The total potential value of the award is $4,917.92, with a period of performance through February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,441.36, is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medical product, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2025. This award is part of AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 ml vial medical products. The contract has a ceiling value of $9,786.84 and a completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract without a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,892.20 firm fixed-price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a period of performance through January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This federal contract award, valued at $1,009.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the delivery of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUS30Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to supply RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a potential value of $3,782.96 and a completion date of February 27, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. The contract has no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, and its parent company is Cencora, Inc., which does business as Amerisourcebergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 2/26/24 |